TA
Tectonic Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.29M | Buy |
50,066
+5,662
| +13% | +$1.05M | 0.54% | 48 |
|
|
2025
Q1 | $9.3M | Buy |
44,404
+2,386
| +6% | +$500K | 0.58% | 40 |
|
|
2024
Q4 | $7.47M | Buy |
42,018
+5,693
| +16% | +$1.01M | 0.49% | 49 |
|
|
2024
Q3 | $7.17M | Buy |
36,325
+3,946
| +12% | +$779K | 0.47% | 51 |
|
|
2024
Q2 | $5.55M | Buy |
32,379
+2,458
| +8% | +$422K | 0.4% | 51 |
|
|
2024
Q1 | $5.45M | Buy |
29,921
+1,005
| +3% | +$183K | 0.42% | 50 |
|
|
2023
Q4 | $4.48M | Buy |
28,916
+1,882
| +7% | +$292K | 0.38% | 58 |
|
|
2023
Q3 | $4.03M | Buy |
27,034
+2,542
| +10% | +$379K | 0.38% | 57 |
|
|
2023
Q2 | $3.3M | Buy |
24,492
+3,169
| +15% | +$427K | 0.41% | 57 |
|
|
2023
Q1 | $3.4M | Buy |
21,323
+4,197
| +25% | +$669K | 0.46% | 51 |
|
|
2022
Q4 | $2.77M | Buy |
17,126
+2,994
| +21% | +$484K | 0.43% | 50 |
|
|
2022
Q3 | $1.9M | Buy |
14,132
+2,807
| +25% | +$377K | 0.35% | 58 |
|
|
2022
Q2 | $1.73M | Buy |
11,325
+2,179
| +24% | +$334K | 0.32% | 56 |
|
|
2022
Q1 | $1.48M | Buy |
9,146
+1,161
| +15% | +$188K | 0.26% | 66 |
|
|
2021
Q4 | $1.08M | Buy |
7,985
+3,913
| +96% | +$530K | 0.19% | 74 |
|
|
2021
Q3 | $439K | Buy |
4,072
+1,152
| +39% | +$124K | 0.09% | 124 |
|
|
2021
Q2 | $329K | Buy |
2,920
+468
| +19% | +$52.7K | 0.07% | 134 |
|
|
2021
Q1 | $266K | Buy |
2,452
+586
| +31% | +$63.6K | 0.07% | 140 |
|
|
2020
Q4 | $200K | Buy |
+1,866
| New | +$200K | 0.05% | 152 |
|